Beam Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -44.8% | -44.8% | -25.1% |
| FY2022 | -39.4% | -39.4% | -21.5% |
| FY2023 | -13.5% | -13.5% | -9.1% |
| FY2024 | -51.4% | -51.4% | -34.1% |
| FY2025 | -6.5% | -6.5% | -5.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -44.8% | -44.8% | -25.1% |
| FY2022 | -39.4% | -39.4% | -21.5% |
| FY2023 | -13.5% | -13.5% | -9.1% |
| FY2024 | -51.4% | -51.4% | -34.1% |
| FY2025 | -6.5% | -6.5% | -5.4% |